Dan Burrows
Dan Burrows (RSS)
InvestorPlace Feature Writer

Dan Burrows is a veteran of CBS MoneyWatch, AOL's DailyFinance, SmartMoney and MarketWatch from Dow Jones. He writes about the markets and economy with an eye toward long-term investing.

Read complete bio
Recent Articles

Bendgate, iOS 8 Debacles Come at Worst Time for Apple Stock

Sep. 25, 2014, 1:20 pm EDT – The iPhone 6 bendgate debacle and problems with iOS 8 came just as Apple stock is trying to take out multi-year resistance. More 

Japanese Stocks: The Star of the Second Half (EWJ, DXJ)

Sep. 25, 2014, 11:41 am EDT – After a terrible first half, Japanese stocks are clobbering U.S. equities -- and have more room to run. More 

KB Home Slaughtered by Profit and Sales Misses (KBH)

Sep. 24, 2014, 1:20 pm EDT – KB Home missed Wall Street estimates by a wide margin, furthering pressuring KBH stock in a down year for housing stocks. More 

5 Stocks to Sell for October

Sep. 24, 2014, 11:56 am EDT – Technical warning signs are flashing for these S&P 500 names, making them stock to sell now. More 

Analysts Think Alibaba Stock Is a ‘Buy’ … But With Limited Upside

Sep. 23, 2014, 1:15 pm EDT – Wall Street calls Alibaba stock a "buy," but the average and median price targets don't imply anything like big gains. More 

Apple Stock Will Get a Lift From Apple Pay

Sep. 23, 2014, 1:14 pm EDT – Sure, iPhone 6 gets all the attention, but if Apple Pay is even a modest hit, it will be a significant long-term driver of Apple stock. More 

Clorox Stock: Still Great for Retirement (CLX)

Sep. 22, 2014, 2:21 pm EDT – Clorox stock is a boring, dividend machine that lags in up markets -- and that makes it perfect for retirement portfolios. More 

Apple Stock Rises on Record Sales of iPhone 6, iPhone 6 Plus

Sep. 22, 2014, 11:08 am EDT – With 10 million sold over the first weekend, the iPhone 6 and iPhone 6 Plus are huge hits, but not exactly the innovative devices AAPL is known for. More 

3 Cheap Blue-Chip Stocks: Buy, Sell or Hold?

Sep. 19, 2014, 9:20 am EDT – Consider potential for growth as well as dividend stability when examining blue-chip stocks like GE, Cisco and Pfizer. More 

Rite Aid Stock a Sell on Deteriorating Fundamentals and Technicals

Sep. 18, 2014, 11:02 am EDT – Rite Aid stock had a fantastic run, but a lack of new blockbuster drugs from big pharma and a technical sell signal make it time to get out. More